BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 24293047)

  • 1. Correlates of left ventricular mass in chronic hemodialysis recipients.
    Wald R; Goldstein MB; Wald RM; Harel Z; Kirpalani A; Perl J; Yuen DA; Wolf MS; Yan AT
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):349-56. PubMed ID: 24293047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.
    Chan CT; Greene T; Chertow GM; Kliger AS; Stokes JB; Beck GJ; Daugirdas JT; Kotanko P; Larive B; Levin NW; Mehta RL; Rocco M; Sanz J; Schiller BM; Yang PC; Rajagopalan S;
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):251-61. PubMed ID: 22360996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Intradialytic Hypertension with Left Ventricular Mass in Hypertensive Hemodialysis Patients Enrolled in the Blood Pressure in Dialysis (BID) Study.
    Shamir AR; Karembelkar A; Yabes J; Yao Y; Miskulin D; Gassman J; Ploth D; Negrea L; Paine S; Rahman M; Kwong RY; Zager P; Jhamb M
    Kidney Blood Press Res; 2018; 43(3):882-892. PubMed ID: 29870977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling.
    Chan CT; Greene T; Chertow GM; Kliger AS; Stokes JB; Beck GJ; Daugirdas JT; Kotanko P; Larive B; Levin NW; Mehta RL; Rocco M; Sanz J; Yang PC; Rajagopalan S;
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2106-16. PubMed ID: 23970131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic values of left ventricular mass index progression in incident peritoneal dialysis patients : a prospective cohort study.
    Chen Y; Dai S; Ge X; Shang D; Xie Q; Hao C; Zhu T
    BMC Nephrol; 2022 May; 23(1):200. PubMed ID: 35641920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network Trials.
    Raimann JG; Chan CT; Daugirdas JT; Depner T; Greene T; Kaysen GA; Kliger AS; Kotanko P; Larive B; Beck G; Lindsay RM; Rocco MV; Chertow GM; Levin NW;
    Kidney Blood Press Res; 2021; 46(6):768-776. PubMed ID: 34644706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of long-functioning hemodialysis vascular access with prevalence of left ventricular hypertrophy in kidney transplant recipients.
    Kolonko A; Kujawa-Szewieczek A; Szotowska M; Kuczera P; Chudek J; Więcek A
    Biomed Res Int; 2014; 2014():603459. PubMed ID: 24616896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis.
    Khangura J; Culleton BF; Manns BJ; Zhang J; Barnieh L; Walsh M; Klarenbach SW; Tonelli M; Sarna M; Hemmelgarn BR;
    BMC Nephrol; 2010 Jun; 11():13. PubMed ID: 20576127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Infection Is Associated with Greater Left Ventricular Mass in the Multicenter AIDS Cohort Study.
    Hutchins E; Wang R; Rahmani S; Nakanishi R; Haberlen S; Kingsley L; Witt MD; Palella FJ; Jacobson L; Budoff MJ; Post WS
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):755-761. PubMed ID: 31044604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone is associated with left ventricular hypertrophy in hemodialysis patients.
    Feniman De Stefano GM; Zanati-Basan SG; De Stefano LM; Silva VR; Xavier PS; Barretti P; da Silva Franco RJ; Caramori JC; Martin LC
    Ther Adv Cardiovasc Dis; 2016 Oct; 10(5):304-13. PubMed ID: 27122492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials.
    Chan CT; Kaysen GA; Beck GJ; Li M; Lo J; Rocco MV; Kliger AS;
    Am J Nephrol; 2018; 47(3):208-217. PubMed ID: 29621747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study.
    Rider OJ; Francis JM; Ali MK; Byrne J; Clarke K; Neubauer S; Petersen SE
    J Cardiovasc Magn Reson; 2009 Apr; 11(1):9. PubMed ID: 19393079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low pulse pressure and high serum complement C1q are risk factors for hemodialysis headache: A case-control study.
    Gan Q; Zhang L; Fang Y; Yang L; Shi M; Xiao Z
    Headache; 2024 Mar; 64(3):285-298. PubMed ID: 38429985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial toxicity in people with chronic kidney disease undergoing hemodialysis treatment.
    Silva ECS; Mantovani MF; Nogueira LA; Küchler ML; Cassi CCAV; Kalinke LP
    Rev Bras Enferm; 2023; 76(4):e20220671. PubMed ID: 37672464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal hemodialysis prescription: do children need more than a urea dialysis dose?
    Michel F; Ariane Z; Betti S; Claus Peter S
    Int J Nephrol; 2011; 2011():951391. PubMed ID: 21660260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.
    Binnenmars SH; Hoogslag GE; Yeung SMH; Brouwers FP; Bakker SJL; van Gilst WH; Gansevoort RT; Navis G; Voors AA; de Borst MH
    J Am Heart Assoc; 2022 Aug; 11(15):e024952. PubMed ID: 35876420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Left Ventricular Characteristics Assessed by Cardiac Magnetic Resonance Imaging and Cardiovascular Biomarkers Related to Kidney Transplantation.
    Prasad GVR; Yan AT; Nash MM; Kim SJ; Wald R; Wald R; Lok C; Gunaratnam L; Karur GR; Kirpalani A; Connelly PW
    Can J Kidney Health Dis; 2018; 5():2054358118809974. PubMed ID: 30542623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Gadolinium-Free Cardiac Fibrosis Imaging in End Stage Renal Disease Patients Reveals A Longitudinal Correlation with Structural and Functional Decline.
    Stromp TA; Spear TJ; Holtkamp RM; Andres KN; Kaine JC; Alghuraibawi WH; Leung SW; Fornwalt BK; Vandsburger MH
    Sci Rep; 2018 Nov; 8(1):16972. PubMed ID: 30451960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
    Stöhr R; Schuh A; Heine GH; Brandenburg V
    Front Endocrinol (Lausanne); 2018; 9():351. PubMed ID: 30013515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing Cardiac Involvement in Chronic Kidney Disease Using CMR-a Systematic Review.
    Mangion K; McDowell K; Mark PB; Rutherford E
    Curr Cardiovasc Imaging Rep; 2018; 11(1):2. PubMed ID: 29497467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.